Chargé dAffaires Médicales Junior

Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialization of life-changing medicines. As a leader in rare diseases for more than 25 years, Alexion has developed and commercializes two approved complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria ( PNH) and atypical hemolytic uremic syndrome (a HUS), as well as the first and only approved complement inhibitor to treat anti-acetylcholine recep...